TT/I  Harvard University Office of Technology Development

https://otd.harvard.edu/





     Office Locations:

Richard A. and Susan F. Smith Campus Center, Suite 727E
1350 Massachusetts Avenue
Cambridge, MA 02138
Phone: 617-495-3067
Fax: 617-495-9568

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Seed


 

Industries:

  • Information Technology

  •  

    Description:

    The Harvard Office of Technology Development (OTD) is responsible for all activities pertaining to the evaluation, patenting and licensing of new inventions and discoveries made at Harvard University and Harvard Medical School. OTD also serves to further the development of Harvard technologies through the establishment of sponsored research collaborations with industry. OTD's Accelerator Fund had a committed capital of $1 million for 2011 to support investigator-initiated projects through proof-of-principle. The Fund has been structured as an 'evergreen' fund, thus helping to support further innovation and applied research at Harvard. The 100+ Harvard startups launched in the past 5 years have collectively raised more than $4.4 billion in financing.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alan D. Gordon Director of Business Development
    Curtis Keith PhD Chief Scientific Officer
    Grant R. Zimmermann PhD Managing Director of Business Development
    Irit Ben-Chelouche Director of Business Development HMS
    Isaac T. Kohlberg Senior Associate Provost and Chief Tech. Development Officer

     

    Portfolio companies include:


      Elevian


      Iome Bio


      Kula Bio


      Perusall


      Root


      Vizgen


      Voxel8


      Whetlab


      Zapata


     

    Recent News: